Antiretroviral therapy at conception in pregnant women with HIV in Italy: Wide range of variability and frequent exposure to contraindicated drugs

Antiviral Therapy

Volumn 11, Issue 7, 2006, Pages 941-946

  Floridia, Marco ^a   Tamburrini, Enrica ^b   Ravizza, Marina ^c   Anzidei, Gianfranco ^d   Tibaldi, Cecilia ^e   Bucceri, Anna ^c   Maccabruni, Anna ^f   Guaraldi, Giovanni ^g   Meloni, Alessandra ^h   Probizer, Maria Fernanda Ravagni ^c   Guerra, Brunella ⁱ   Martinelli, Pasquale ^j  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h UNIVERSITY OF CAGLIARI   (Italy)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; ENFUVIRTIDE; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; INDINAVIR; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; BIRTH DEFECT; CONCEPTION; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EXPOSURE; FEMALE; FETUS DEATH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; FEMALE; FERTILIZATION; HIV INFECTIONS; HUMANS; ITALY; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENTINEL SURVEILLANCE;

EID: 33750956541     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. AIDSinfo [homepage on the Internet]. Rockville: U.S. Department of Health and Human Services [Updated 2005 Nov 17; cited 2006 Sept 26]. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Available from: http://aidsinfo.nih. gov/Guidelines/Default.aspx?MenuItem =Guidelines
2. Floridia M, Ravizza M, Tamburrini E, et al. Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect; in press.
3. Antiretroviral Pregnancy Registry Steering Committee. The Antiretroviral Pregnancy Registry Interim Report 1 January 1989 through 31 July 2005 [monograph on the Internet] [cited 2006 Sept 26]. Available from: http://www.apregistry. com/forms/APR_report_1205.pdf
4. Fundarò C, Genovese O, Rendeli C, et al. Myelomeningocele in a child with intrauterine exposure to efavirenz. AIDS, 2002, 16:299-300.
5. Hitti J, Frenkel L, Stek A, et al. - Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022. J Acq Imm Def Syndr 2004; 36:772-776.
6. Bristol-Myers Squibb Company. Healthcare Provider Important Drug Warning Letter [monograph on the Internet] [cited 2006 Sept 26]. Available from: http://www.fda.gov/medwatch/safety/2001/zerit&videx_ letter.htm
7. Sarner L, Fakoya A. Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication. Sex Transm Infect, 2002; 78:58-59.